Mitobridge's Acquisition

Mitobridge was acquired by Astellas Venture Management on December 01, 2017.

Mitobridge, formerly known as Mitokyne, is a biotechnology company focused on mitochondria-related drug discovery and development. The company is utilizing its screening platform to identify and devel…

Articles about Mitobridge's Acquisition: